Conditions: Advanced Malignant Solid Tumors
Keywords: Neratinib Capecitabine Combination Solid Tumor
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
This is an open-label, phase 1 study of a single cohort of neratinib (HKI-272) in combination with capecitabine.

Detailed description:

Arms:
arm 1: Neratinib + Capecitabine

Interventions: intervention 1: Neratinib intervention 2: Capecitabine
Intervention descriptions: intervention 1: 240 mg once daily by mouth. intervention 2: 1500 mg/m\^2 twice daily by mouth.

Protocol document: